Vafseo
1 known investors
Vafseo (vadadustat) is a once-daily oral prescription medicine that treats anemia caused by chronic kidney disease in adults who have been on dialysis for at least three months. It works by increasing erythropoietin to help the body produce more red blood cells, and is marketed by Akebia Therapeutics.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Vafseo do?
- Vafseo (vadadustat) is a once-daily oral prescription medicine that treats anemia caused by chronic kidney disease in adults who have been on dialysis for at least three months. It works by increasing erythropoietin to help the body produce more red blood cells, and is marketed by Akebia Therapeutics.
- Who are Vafseo's investors?
- Vafseo's investors include HEALTHCARE ROYALTY PARTNERS.